SUN PHARMA – Innovcare Lifesciences Acquisition (₹271 Cr Deal)

1. Strategic Acquisition: Sun Pharmaceutical Industries has signed an agreement to acquire 100% stake in Innovcare Lifesciences for ₹271.2 crore (₹2.71 billion) in an all-cash transaction. 2. Portfolio Expansion: The acquisition is aimed at strengthening Sun Pharma’s product portfolio and enhancing its presence in key therapeutic segments within the Indian pharmaceutical market. 3. Growth Through Inorganic Expansion: The deal reflects Sun Pharma’s continued strategy of using targeted acquisitions to drive growth, complementing its organic expansion initiatives. 4. Manageable Deal Size: At ₹271 crore, the acquisition is relatively small compared to Sun Pharma’s scale, making it a low-risk, bolt-on acquisition that can add incremental revenues and products without materially impacting the balance sheet $SUNPHARMA